Mohammed Salmen Bazuqamah

Dr. Mohammed Salmen Bazuqamah

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2024 in Discover Medicine
Verified
Journal Article
Open access
PDF file
MAMohsen Almakrami
Mohsen Almakrami
Mohammed Salmen BazuqamahMohammed Salmen Bazuqamah
Mohammed Salmen Bazuqamah
YAYahya Ahmad Aldashel
Yahya Ahmad Aldashel
MAMesfer Hussain Alyami
Mesfer Hussain Alyami
NANasser Alquraishah
Nasser Alquraishah
JAJafar Almakrami
Jafar Almakrami
Background: Saudi Arabia faces a growing antimicrobial resistance (AMR) problem, exacerbated by the widespread use of antibiotics in clinical and agricultural settings. Despite this, AMR surveillance has been limited, particularly in regions like Najran, making this study critical for informing local and national public health strategies. Aim: This study explored the prevalence of multidrug-resistant, extensively drug-resistant, and Pandrug-resistant bacteria in Najran, Saudi Arabia. Study design: This is a cross-sectional study. Methods: This study included 559 diverse clinical samples (urine, wound, etc.) collected from various departments in King Khaled Hospital, Saudi Arabia. The Phoenix BD instrument was used for complete bacterial identification and antibiotic sensitivity testing. Demographic and clinical data were analyzed statistically. Results: Of the 559 samples, the culture positivity rates were as follows: 51% for Escherichia coli, 22% for Staphylococcus aureus, 14% for Klebsiella pneumoniae, 6% for Acinetobacter baumannii, 6% for Pseudomonas aeruginosa, and 1% for Enterococcus faecium. Majority of the cases were from male (57%), and age 50+ (59%) recorded highest cases. Participants from outpatient department (OPD) ward recorded the highest (56%) cases, while urine sample recorded the highest (49%) cases. About 84% of the isolates were multidrug‑resistance (MDR), 10% were extensively drug‑resistance (XDR), and 6% pandrug‑resistance (PDR). Our analysis showed high sensitivity to Oxazolidonone, Tetracycline, carbapenems, Lipopeptide, Aminoglycopeptide classes of antibiotics. Conclusions: The study revealed a high prevalence of drug resistance, highlighting the critical importance of continued surveillance and research to mitigate the spread of antimicrobial resistance and preserve the effectiveness of existing therapies.

30 September 2024 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
ATAbrar K. Thabit
Abrar K. Thabit
AAAmmar M. Alghamdi
Ammar M. Alghamdi
MMMusaab Y. Miaji
Musaab Y. Miaji
FAFeras S. Alharbi
Feras S. Alharbi
AJAnas F. Jawah
Anas F. Jawah
TGthe Saudi AntiMicrobial Surveillance (SAMS) study group
the Saudi AntiMicrobial Surveillance (SAMS) study group
Background: Pseudomonas aeruginosa is a common pathogen causing healthcare-associated infections. Most surveillance studies from Saudi Arabia that assessed the resistance by P. aeruginosa were conducted in single centers or did not use broth microdilution (BMD), the gold standard test. This is the first national multicenter study to assess the resistance profiles of P. aeruginosa isolates in Saudi Arabia using BMD.Methods: Between 2022 and 2023, isolates from various infection sites were collected from seven hospitals in seven different regions of Saudi Arabia. The isolates were shipped to an academic microbiology lab, where their susceptibility was tested by BMD following Clinical Laboratory Standards Institute guidelines using Sensititre GNX3F plates. %Susceptibility to each antibiotic, and MIC50 and MIC90 were determined.Results: In total, 185 P. aeruginosa isolates were collected. Most isolates came from respiratory specimens (34.1%), followed by urine (21.1%) and skin/soft tissue (17.8%). The highest susceptibility was to amikacin (76.8%). Concurrently, susceptibility to meropenem was 52%, but it was 43.8% to colistin. While all P. aeruginosa isolates met the definition of multidrug-resistance, 41 (22.2%) were difficult-to-treat and 10 (5.4%) were pandrug-resistant. Difficult-to-treat isolates made up 30.3% of skin and soft tissue isolates, 25.4% of respiratory isolates, 21.7% of blood isolates, and 17.9% of urine isolates.Conclusion: Pseudomonas aeruginosa demonstrated an unexpectedly high level of resistance to several commonly used antibiotics. Therefore, antimicrobial stewardship and infection control policies should be strictly enforced by hospitals across the country to optimize treatment, prevent the emergence and spread of resistant strains, and track resistance trends with local antibiograms.

19 February 2025 in Antibiotics
Verified
Journal Article
Open access
PDF file
ATAbrar K. Thabit
Abrar K. Thabit
FAFeras S. Alharbi
Feras S. Alharbi
AJAnas F. Jawah
Anas F. Jawah
AAAmmar M. Alghamdi
Ammar M. Alghamdi
MMMusaab Y. Miaji
Musaab Y. Miaji
KEKhalid Eljaaly
Khalid Eljaaly
Most surveillance studies in Saudi Arabia have been single-centered or did not use the gold standard broth microdilution (BMD) antimicrobial susceptibility test. This is the first study from Saudi Arabia to evaluate the resistance profiles of Acinetobacter baumannii by using BMD on a national level. Between November 2022 and April 2023, isolates from several infection sites were collected from seven hospitals in seven regions of Saudi Arabia. On testing days, BMD was done following Clinical Laboratory Standards Institute standards. Antibiotic susceptibility percentages and MIC50 and MIC90 were calculated. One hundred A. baumannii isolates were included. The highest susceptibility was to tigecycline (39%) and aminoglycosides (22–25%). The MIC90 of all antibiotics were higher than the resistance breakpoint. All isolates (100%) were multidrug-resistant, of which 52% were classified as extensive-drug-resistant, and 42% were identified as pandrug-resistant. The isolates collected from the ear, peritoneal fluid, and the cerebrospinal fluid were all XDR, while 2/3 of the urine isolates (10/15; 66.7%), more than 1/2 of the skin/soft tissue and respiratory isolates (9/16; 56.3% and 22/43; 51.7%, respectively), and 3/8 (37.5%) of the blood isolates met this definition. Conversely, PDR isolates made up 5/8 of blood isolates (62.5%), 8/15 of body fluid isolates (57.14%), and 19/43 (44.2%) of respiratory isolates. A. baumannii showed a surprisingly high resistance to multiple commonly used antibiotics. Infection control policies and antimicrobial stewardship should be implemented by hospitals throughout the country to improve treatment, track resistance trends with local antibiograms, and prevent the development of resistant strains.

31 March 2024 in The Journal of Infection in Developing Countries
Verified
Journal Article
Open access
PDF file
HSHadi Al Sulayyim
Hadi Al Sulayyim
RIRohani Ismail
Rohani Ismail
AHAbdullah Al Hamid
Abdullah Al Hamid
Mohammed Salmen BazuqamahMohammed Salmen Bazuqamah
Mohammed Salmen Bazuqamah
NGNoraini Abdul Ghafar
Noraini Abdul Ghafar
Introduction: Prevalence of antibiotic resistance (AR) during the coronavirus 2019 (COVID-19) pandemic was higher than pre-pandemic times. This study determined the prevalence and patterns of AR among Gram-positive and negative bacteria before, during and after COVID-19 in Saudi Arabia and identified the associated factors. Methodology: A retrospective cross-sectional study was employed to identify patients with positive AR bacteria between March 2019 and March 2022. The bacterial isolates and patients’ data were identified from laboratory and medical records departments retrospectively. Binary logistic regression analysis was performed to identify the factors associated with AR and deaths. Multinominal logistic regression was applied to confirm the factors associated with AR classification. Results: AR Gram-negative bacteria decreased during and after the pandemic. However, S. aureus showed a negligible increase in resistance rate after pandemic, while E. faecium, recorded a higher-than-average resistance rate during the pandemic. The prevalence of pan drug resistance (PDR) during the pandemic (85.7%) was higher than before (0%) and after (14.3%), p = 0.001. The length of stay and time were significant predictors for AR classification. The odds of multi drug resistance (MDR) development to PDR during the pandemic were 6 times higher than before and after (OR = 6.133, CI =, p = 0.020). Age, nationality, COVID-19 infection, smoking, liver disease, and type and number of bacteria were associated with death of patients with positive AR. Conclusions: Further studies are recommended to explore the prevalence of PDR and to justify the increased rates of E. faecium AR during the COVID-19 pandemic.

15 January 2025 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
HAHuda J. Aljedaani
Huda J. Aljedaani
MMManea F. Al Munjem
Manea F. Al Munjem
Mohammed Salmen BazuqamahMohammed Salmen Bazuqamah
Mohammed Salmen Bazuqamah
ATAbrar K. Thabit
Abrar K. Thabit

11 November 2024
Verified
Journal Article
Closed access
MAMohsen Almakrami
Mohsen Almakrami
Mohammed Salmen BazuqamahMohammed Salmen Bazuqamah
Mohammed Salmen Bazuqamah
YAYahya Ahmad Aldashel
Yahya Ahmad Aldashel
MAMesfer Hussain Alyami
Mesfer Hussain Alyami
NANasser Alquraishah
Nasser Alquraishah
HAHadi Alswar
Hadi Alswar